Mycosis fungoides epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(27 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Cutaneous T cell lymphoma}}
{{Mycosis fungoides}}
{{CMG}}; {{AE}} {{AS}}
{{CMG}}; {{AE}} {{S.G.}}
==Overview==
==Overview==
The incidence of mycosis fungoides increases with age; the median age at diagnosis is between 45 and 55 years of age. The median age at diagnosis of Sézary syndrome is 60 years of age. In the United States, males are more commonly affected with cutaneous T cell lymphoma than females. In the United States, cutaneous T cell lymphoma usually affects individuals of the African American race.<ref name="radio">Mycosis fungoides. Radiopaedia.http://radiopaedia.org/articles/mycosis-fungoides Accessed on January 21, 2016</ref>
The incidence of mycosis fungoides increases with [[Ageing|age]]; the median age at [[diagnosis]] is between 45 and 55 years of [[age]]. In the United States, [[Male|males]] are more commonly affected with mycosis fungoides than [[Female|females]]. In the United States, mycosis fungoides usually affects individuals of the African American [[race]].
==Epidemiology and demographics==
==Epidemiology and demographics==
===Age===
===Age===
* The incidence of mycosis fungoides increases with age; the median age at diagnosis is between 45 and 55 years of age.  
* The incidence of mycosis fungoides increases with age; the median age at [[diagnosis]] is between 40 and 60 years of [[age]].<ref name="FossGirardi2017">{{cite journal|last1=Foss|first1=Francine M.|last2=Girardi|first2=Michael|title=Mycosis Fungoides and Sezary Syndrome|journal=Hematology/Oncology Clinics of North America|volume=31|issue=2|year=2017|pages=297–315|issn=08898588|doi=10.1016/j.hoc.2016.11.008}}</ref>
* The median age at diagnosis of Sézary syndrome is 60 years of age.
* Mycosis fungoidesaffects individuals younger than majority of patients and this diseases are reported in children.<ref name="FossGirardi2017">{{cite journal|last1=Foss|first1=Francine M.|last2=Girardi|first2=Michael|title=Mycosis Fungoides and Sezary Syndrome|journal=Hematology/Oncology Clinics of North America|volume=31|issue=2|year=2017|pages=297–315|issn=08898588|doi=10.1016/j.hoc.2016.11.008}}</ref>
===Gender===
===Gender===
In the United States, males are more commonly affected with cutaneous T cell lymphoma than females.<ref name= radio>Mycosis fungoides. Radiopaedia.http://radiopaedia.org/articles/mycosis-fungoides Accessed on January 21, 2016</ref>
* In the United States, [[Male|males]] are more commonly affected with mycosis fungoides than [[Female|females]].<ref name="FossGirardi2017" /><ref name="radio">Mycosis fungoides. Radiopaedia.http://radiopaedia.org/articles/mycosis-fungoides Accessed on January 21, 2016</ref>
 
===Race===
===Race===
In the United States, cutaneous T cell lymphoma usually affects individuals of the African American race.<ref name= radio>Mycosis fungoides. Radiopaedia.http://radiopaedia.org/articles/mycosis-fungoides Accessed on January 21, 2016</ref>
* In the United States, mycosis fungoides affects individuals of the African American [[race]].<ref name="FossGirardi2017" /><ref name="radio" />
 
===Region===
*The majority of mycosis fungoides (primary and secondary) cases are reported in geographical variances folllowing viral-induced lymphomas might show partial geographical restriction.<ref name="Lome-MaldonadoHernández-Salazar2017">{{cite journal|last1=Lome-Maldonado|first1=Carmen|last2=Hernández-Salazar|first2=Amparo|last3=García-Vera|first3=JorgeAndrés|last4=Charli-Joseph|first4=Yann|last5=Ortiz-Pedroza|first5=Guadalupe|last6=Méndez-Flores|first6=Silvia|last7=Orozco-Topete|first7=Rocío|last8=Morales-Leyte|first8=AnaLilia|last9=Domínguez-Cherit|first9=Judith|title=Oral and cutaneous lymphomas other than mycosis fungoides and sézary syndrome in a mexican cohort: Recategorization and evaluation of international geographical disparities|journal=Indian Journal of Dermatology|volume=62|issue=2|year=2017|pages=158|issn=0019-5154|doi=10.4103/ijd.IJD_34_17}}</ref>


==References==
==References==
{{Reflist|1}}
{{Reflist|2}}


[[Category:Disease]]
[[Category:Disease]]
Line 22: Line 26:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Hematology]]
[[Category:Immunology]]

Latest revision as of 16:13, 6 February 2019

Mycosis fungoides Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mycosis Fungoides from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X-Ray

CT Scan

MRI

Echocardiography and Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mycosis fungoides epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mycosis fungoides epidemiology and demographics

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mycosis fungoides epidemiology and demographics

CDC on Mycosis fungoides epidemiology and demographics

Mycosis fungoides epidemiology and demographics in the news

Blogs on Mycosis fungoides epidemiology and demographics

Directions to Hospitals Treating Mycosis fungoides

Risk calculators and risk factors for Mycosis fungoides epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]

Overview

The incidence of mycosis fungoides increases with age; the median age at diagnosis is between 45 and 55 years of age. In the United States, males are more commonly affected with mycosis fungoides than females. In the United States, mycosis fungoides usually affects individuals of the African American race.

Epidemiology and demographics

Age

  • The incidence of mycosis fungoides increases with age; the median age at diagnosis is between 40 and 60 years of age.[1]
  • Mycosis fungoidesaffects individuals younger than majority of patients and this diseases are reported in children.[1]

Gender

  • In the United States, males are more commonly affected with mycosis fungoides than females.[1][2]

Race

  • In the United States, mycosis fungoides affects individuals of the African American race.[1][2]

Region

  • The majority of mycosis fungoides (primary and secondary) cases are reported in geographical variances folllowing viral-induced lymphomas might show partial geographical restriction.[3]

References

  1. 1.0 1.1 1.2 1.3 Foss, Francine M.; Girardi, Michael (2017). "Mycosis Fungoides and Sezary Syndrome". Hematology/Oncology Clinics of North America. 31 (2): 297–315. doi:10.1016/j.hoc.2016.11.008. ISSN 0889-8588.
  2. 2.0 2.1 Mycosis fungoides. Radiopaedia.http://radiopaedia.org/articles/mycosis-fungoides Accessed on January 21, 2016
  3. Lome-Maldonado, Carmen; Hernández-Salazar, Amparo; García-Vera, JorgeAndrés; Charli-Joseph, Yann; Ortiz-Pedroza, Guadalupe; Méndez-Flores, Silvia; Orozco-Topete, Rocío; Morales-Leyte, AnaLilia; Domínguez-Cherit, Judith (2017). "Oral and cutaneous lymphomas other than mycosis fungoides and sézary syndrome in a mexican cohort: Recategorization and evaluation of international geographical disparities". Indian Journal of Dermatology. 62 (2): 158. doi:10.4103/ijd.IJD_34_17. ISSN 0019-5154.


Template:WikiDoc Sources